Indiva Ltd
XTSX:NDVA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Indiva Ltd
XTSX:NDVA
|
CA |
|
Euro Ressources SA
PAR:EUR
|
FR |
|
Xvivo Perfusion AB
STO:XVIVO
|
SE |
|
A
|
Associated British Foods PLC
OTC:ASBFY
|
UK |
|
R
|
Ruentex Engineering & Construction Co Ltd
TWSE:2597
|
TW |
|
W
|
WAG Payment Solutions PLC
LSE:WPS
|
UK |
|
I
|
Itama Ranoraya PT
IDX:IRRA
|
ID |
|
S
|
Santa Fe Minerals Ltd
ASX:SFM
|
AU |
|
D
|
Dalian Insulator Group Co Ltd
SZSE:002606
|
CN |
|
Hotel Grand Central Ltd
SGX:H18
|
SG |
|
A
|
AcelRx Pharmaceuticals Inc
F:R5X
|
US |
Balance Sheet
Balance Sheet Decomposition
Indiva Ltd
Indiva Ltd
Balance Sheet
Indiva Ltd
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
21
|
20
|
1
|
0
|
2
|
3
|
2
|
|
| Cash |
21
|
20
|
1
|
0
|
2
|
3
|
2
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
1
|
1
|
5
|
6
|
4
|
6
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
6
|
4
|
5
|
|
| Other Receivables |
0
|
1
|
1
|
4
|
0
|
0
|
1
|
|
| Inventory |
0
|
1
|
8
|
6
|
6
|
4
|
5
|
|
| Other Current Assets |
0
|
1
|
1
|
1
|
1
|
1
|
0
|
|
| Total Current Assets |
22
|
22
|
11
|
12
|
16
|
12
|
13
|
|
| PP&E Net |
5
|
9
|
22
|
23
|
22
|
23
|
21
|
|
| PP&E Gross |
0
|
0
|
22
|
23
|
22
|
23
|
21
|
|
| Accumulated Depreciation |
0
|
0
|
1
|
3
|
4
|
5
|
6
|
|
| Intangible Assets |
0
|
0
|
0
|
2
|
2
|
2
|
1
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
1
|
2
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
3
|
3
|
2
|
3
|
2
|
2
|
|
| Total Assets |
28
N/A
|
36
+30%
|
38
+6%
|
39
+3%
|
42
+8%
|
38
-11%
|
38
0%
|
|
| Liabilities | ||||||||
| Accounts Payable |
0
|
2
|
10
|
7
|
7
|
13
|
15
|
|
| Accrued Liabilities |
0
|
0
|
0
|
5
|
1
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
4
|
6
|
7
|
1
|
0
|
3
|
|
| Other Current Liabilities |
0
|
0
|
1
|
5
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
6
|
17
|
24
|
9
|
13
|
18
|
|
| Long-Term Debt |
8
|
0
|
2
|
3
|
21
|
22
|
19
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Total Liabilities |
9
N/A
|
6
-26%
|
19
+192%
|
28
+49%
|
30
+8%
|
36
+19%
|
38
+7%
|
|
| Equity | ||||||||
| Common Stock |
20
|
37
|
37
|
42
|
57
|
57
|
60
|
|
| Retained Earnings |
2
|
8
|
19
|
36
|
51
|
61
|
67
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
5
|
6
|
6
|
7
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
19
N/A
|
29
+56%
|
19
-34%
|
11
-42%
|
12
+10%
|
2
-83%
|
0
N/A
|
|
| Total Liabilities & Equity |
28
N/A
|
36
+30%
|
38
+6%
|
39
+3%
|
42
+8%
|
38
-11%
|
38
0%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
61
|
83
|
84
|
110
|
146
|
147
|
186
|
|